David P. Schenkein - 08 Sep 2023 Form 3 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/ David P. Schenkein
Issuer symbol
REGN
Transactions as of
08 Sep 2023
Net transactions value
$0
Form type
3
Filing time
12 Sep 2023, 16:01:39 UTC
Previous filing
23 Jun 2023
Next filing
04 Jan 2024

No securities are beneficially owned.